VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
An anticancer C-Kit kinase inhibitor is reengineered to make it more active and less cardiotoxic.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
An anticancer C-Kit kinase inhibitor is reengineered to make it more active and less cardiotoxic.
An anticancer C-Kit kinase inhibitor is reengineered to make it more active and less cardiotoxic. J Clin Invest. 2007 Dec; 117(12):4044-54.
View in:
PubMed
subject areas
Animals
Benzamides
Cardiotoxins
Drug Screening Assays, Antitumor
Fusion Proteins, bcr-abl
Gastrointestinal Stromal Tumors
Heart Diseases
Humans
Imatinib Mesylate
K562 Cells
MAP Kinase Kinase 4
Neoplasms, Experimental
Piperazines
Protein Kinase Inhibitors
Protein-Tyrosine Kinases
Proto-Oncogene Proteins c-kit
Pyrimidines
Rats
Rats, Sprague-Dawley
authors with profiles
GABRIEL LOPEZ
JAMES A BANKSON
ANIL K SOOD
LINGEGOWDA SELANERE MANGALA